Gordin, Daniel
Saraheimo, Markku
Tuomikangas, Jaana
Soro-Paavonen, Aino
Forsblom, Carol
Paavonen, Karri
Steckel-Hamann, Birgit
Harjutsalo, Valma
Nicolaou, Loizos
Pavo, Imre
Koivisto, Veikko http://orcid.org/0000-0001-9585-2297
Groop, Per-Henrik
Article History
Received: 26 October 2018
Accepted: 16 April 2019
First Online: 22 May 2019
Compliance with ethical standards
:
: IP and BS-H are employees and VK is a contractor of Eli Lilly & Co, the manufacturer of Humalog. P-HG has received lecture honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Elo Water, Genzyme, Medscape, MSD, Novartis, Novo Nordisk, and Sanofi, and is on the advisory boards of AbbVie, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, MSD, Novartis, Novo Nordisk, and Sanofi. P-HG has received a grant from Eli Lilly for this study as well as another investigator-initiated grant from Roche. The other authors have nothing to disclose.
: The study protocol is in accordance with the Declaration of Helsinki as revised in 2000 and was approved by the local ethics committee in each study center.
: Written informed consent was obtained from each patient.